Executive SummaryScientists at CellGate Inc. say they have demonstrated that linking short peptide polymers of the amino acid arginine to a drug molecule will both increase the molecule's water solubility and help get it through the cell membrane. Moreover, this proprietary strategy for enhancing drug bioavailability appears to work with any class of compound. Harnessing this universal transporter technology, CellGate plans to build a service business around taking well-characterized molecules and turning them into better drugs.
You may also be interested in...
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.